Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
State Street SPDR MSCI Europe Health Care UCITS ETF (HLTH.L)
About this ETF
The Fund's primary objective is to replicate the investment returns generated by substantial and mid-sized European healthcare firms.
Price
Top 10 holdings
| Roche Holding Ltd ROP.SW | 15.83% |
| Novartis AG NOVN.SW | 15.24% |
| AstraZeneca PLC AZN.L | 14.08% |
| Novo Nordisk A/S Class B NOVO-B.CO | 8.58% |
| GSK plc GSK.L | 5.77% |
| Sanofi SA SAN.PA | 5.14% |
| EssilorLuxottica SA EL.PA | 3.19% |
| Bayer AG BAYN.DE | 3.05% |
| argenx SE ARGX.BR | 2.92% |
| Lonza Group AG LONN.SW | 2.76% |
Sector mix
Price chart
Returns
| 1 month | +2.50% |
| 3 months | +2.13% |
| 6 months | -1.84% |
| Year to date | +2.86% |
| 1 year | +14.00% |
| 3 years (ann.) | +5.96% |
| 5 years (ann.) | +5.09% |
| 10 years (ann.) | +6.34% |
Risk profile
| Volatility (1y, ann.) | 17.08% |
| Sharpe (1y) | 0.85 |
| Sharpe (3y) | 0.44 |
| Sortino (1y) | 1.42 |
| Max drawdown (1y) | -12.57% |
| Max drawdown (5y) | -26.57% |
| Max drawdown (full) | -26.57% |
| Beta vs S&P 500 (1y) | 0.28 |
| Correlation vs S&P 500 (1y) | 0.20 |
Technical outlook as of 2026-07-13
The Monte Carlo cone is drawn on the price chart above (Forecast overlay); RSI, MACD and the rest of the oscillators live in its indicator panels.
Full holdings
| Constituent | ISIN | Market value | Weight |
|---|---|---|---|
| Loading… | |||
Sector breakdown
Geographic exposure
Cost vs. peers
Comparison universe: 6,948 funds of the same asset class.
Cost impact calculator
Dividend history
Accumulating share class Income is reinvested inside the fund instead of being paid out. (inferred from the absence of distributions)
No distributions on record — accumulating share classes reinvest income instead of paying it out.
ESG profile
No ESG estimate available: none of the scored universe overlaps this portfolio (typical for bond, commodity or synthetic funds).
Scored coverage: 0.0% of the portfolio by weight.
Similar ETFs
| Fund | TER | AUM (USD) | Yield (TTM) | Return 1y | Sharpe 1y |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.05% | +19.93% | 1.48 |
| Vanguard S&P 500 ETF VOO | 0.03% | 1.70T | 1.07% | +19.68% | 1.49 |
| iShares Core S&P 500 ETF IVV | 0.03% | 894.38B | 1.09% | +19.68% | 1.49 |
| State Street SPDR S&P 500 ETF SPY | 0.09% | 789.23B | 1.00% | +19.71% | 1.49 |
| SPDR S&P 500 ETF Trust 1557.T | 0.09% | 789.09B | 0.49% | +37.54% | 2.26 |
| State Street SPDR S&P 500 ETF SPY.AX | 0.09% | 788.13B | 1.00% | +11.84% | 1.13 |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 2.61% | +20.58% | 1.21 |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 0.43% | +28.14% | 1.43 |
| Vanguard Growth ETF VUG | 0.03% | 393.80B | 0.39% | +16.85% | 0.99 |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 2.60% | +21.64% | 1.23 |
Cheaper alternatives
No fund of the class reaches 60% portfolio overlap — showing the cheapest funds of the class instead.
| Fund | TER | AUM (USD) | Overlap |
|---|---|---|---|
| iShares Core MSCI EAFE ETF IEFA | 0.07% | 187.22B | 7.3% |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 5.5% |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 4.0% |
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 0.0% |
| State Street SPDR Portfolio S&P 500 ETF SPYM | 0.02% | 159.32B | 0.0% |
